Generic and Biosimilar Medications

News

Thursday April 30 2026

UK in a Changing Europe

Our chief executive Mark Samuels writes for the think tank UK in a Changing Europe about why medicines resilience must be at the heart of ay evolving relationship with the European Union

UK in a Changing Europe

Mark Samuels outlines his argument for greater UK-EU cooperation to ensure that access to medicines across Europe are as shielded as possible from geopolitical shocks.

 

“Stability isn’t nearly so spectacular as instability,” pointed out Aldous Huxley. And, of course, global instability is no longer a distant geopolitical concern – it is now affecting NHS patients directly. Recent US foreign policy decisions, particularly those that have intensified tensions in Iran and across the Middle East, have sent shockwaves through global supply chains. Those ripples are now reaching the UK’s medicine cabinets, and the NHS is a few weeks away from potential shortages.

 

Read the full article

Generic and Biosimilar Medications
Up